Impact of Body Mass Index in the Cardioverter Efficacy of Amiodarone in Persistent Atrial Fibrillation.

Carmen LigeroPau Riera Amine El Amrani Victor Bazan José M Guerra Silvia HerraezXavier ViñolasJosep M Alegret

Published in: Pharmaceuticals (Basel, Switzerland) (2024)

We observed a negative relationship between an increased BMI and the efficacy of amiodarone for reversion to SR, suggesting a negative clinical impact of excess body fat in its efficacy.

Keyphrases

body mass index
atrial fibrillation
heart failure
coronary artery disease